Viva Cyte Dandamalin Tsarin Manhaja daga Livia Stevenin

Zane Viva Cyte Dandamalin Tsarin Manhaja daga Livia Stevenin mai nasara ne mai daraja sosai na 2025 Kyautar A' Design Award ta Azurfa a Rukunin Gasar Fuskar Amfani.

AzurfaFuskar Amfani· 2025

Viva Cyte Dandamalin Tsarin Manhaja

daga Livia Stevenin

Abokin Ciniki: Cellply

Mai Nasarar Kyautar A' Design Award ta Azurfa a Rukunin Fuskar Amfani

56,621

Mai Nasara da Aka Tabbatar

Tabbatar da Matsayin Kyauta na #168358

Ziyarci Shafin Duba a A' Design Award Sanarwar Manema Labarai Alamar Kyauta

Launuka

Ƙirar

Game da Viva Cyte Dandamalin Tsarin Manhaja

Viva Cyte babban tsarin manhaja ne na zamani wanda aka ƙera don sauƙaƙa haɓaka maganin ƙwayoyin salula ta hanyar haɗa aiki ta atomatik, bincike mai yawa cikin sauri, da kuma ƙwarewar mai amfani mai sauƙin fahimta. Ya ƙunshi Manhajan Sarrafawa (CSW) don gudanar da gwaje-gwajen halittu da Manhajan Nazari (ASW) don ciro bayanai masu ma'ana. Aikin atomatik na AI yana rage kurakurai na ɗan adam, yana inganta daidaito, yana kuma haɓaka sauƙin amfani, yana baiwa masu bincike damar bi tsarin aiki masu rikitarwa cikin inganci yayin da ake hanzarta ci gaban magungunan kiwon lafiya.

Amincewa

Game da Kyautar A' Design Award ta Azurfa

Zanen Viva Cyte Dandamalin Tsarin Manhaja ya lashe Kyautar A' Design Award ta Azurfa, wata karramawa mai tsananin daraja da ake bai wa zane-zane na matakin koli, masu kyau sosai kuma masu burgewa. Waɗanda suka lashe kyautar Azurfa ayyuka ne masu haske sosai da ƙirƙira mai yawa waɗanda ke nuna ƙwarewa, baiwa da kaifin tunanin masu zanensu. Ana sa ran zanen Viva Cyte Dandamalin Tsarin Manhaja ya zama aiki mai ban mamaki, abin koyi, mai ƙwarewa sosai kuma mai ƙirƙire-ƙirƙire mai zurfi. Wannan zane da ya lashe Kyautar A' Design Award ta Azurfa ƙirƙira ce mai abin lura sosai, da ake sha'awa, wacce ke amfanar da kuma kai iyakokin fasaha, kimiyya, zane da fasahar zamani gaba. Zanen Viva Cyte Dandamalin Tsarin Manhaja ƙirƙira ce da ake yi wa hassada sosai wacce ke tada sha'awa, tana kawo jin daɗi kuma tana haifar da mamaki da al'ajabi.

Bayan Ƙirar

Kayan Manema Labarai

Bayanin ƙungiyar, membobinta da cikakkun bayanai na fasaha da mai ƙirar ya bayar.

Siffofi Na Musamman: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Girma da Fakitin: Design: Figma
Front-end: React JS
Design System: Bento
Kalmomin Alama: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Fasahar Samarwa: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Ƙalubalen Zane: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Bincike: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Wahayi: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Tsawon Lokacin Aikin: The project started in January 2022 in Milan and finished in August 2024.
Tsarin Aiki: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Mambobin Ƙungiya: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Godiyar Hotuna: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),